Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 396

1.

Achieving Thoracic Oncology data collection in Europe: a precursor study in 35 Countries.

Rich A, Baldwin D, Alfageme I, Beckett P, Berghmans T, Brincat S, Burghuber O, Corlateanu A, Cufer T, Damhuis R, Danila E, Domagala-Kulawik J, Elia S, Gaga M, Goksel T, Grigoriu B, Hillerdal G, Huber RM, Jakobsen E, Jonsson S, Jovanovic D, Kavcova E, Konsoulova A, Laisaar T, Makitaro R, Mehic B, Milroy R, Moldvay J, Morgan R, Nanushi M, Paesmans M, Putora PM, Samarzija M, Scherpereel A, Schlesser M, Sculier JP, Skrickova J, Sotto-Mayor R, Strand TE, Van Schil P, Blum TG.

BMC Cancer. 2018 Nov 20;18(1):1144. doi: 10.1186/s12885-018-5009-y.

2.

ERS Statement on harmonised standards for lung cancer registration and lung cancer services in Europe.

Rich AL, Baldwin DR, Beckett P, Berghmans T, Boyd J, Faivre-Finn C, Galateau-Salle F, Gamarra F, Grigoriu B, Hansen NC, Hardavella G, Jakobsen E, Jovanovic D, Konsoulova A, Massard G, McPhelim J, Meert AP, Milroy R, Mutti L, Paesmans M, Peake MD, Putora PM, de Ruysscher D, Sculier JP, Schepereel A, Subotic D, Van Schil P, Blum TG.

Eur Respir J. 2018 Oct 25. pii: 1800610. doi: 10.1183/13993003.00610-2018. [Epub ahead of print]

PMID:
30361252
3.

Les Actualités en Médecine factuelle - Edition 2018.

Sculier JP.

Rev Med Brux. 2018;39(3):185-187. French. No abstract available.

PMID:
29964393
4.

La casuistique.

Sculier JP.

Rev Med Brux. 2018;39(3):132-133. French. No abstract available.

PMID:
29964387
5.

Survivre au cancer du poumon : détresses et résiliences.

Sculier JP, Fauconnier A.

Rev Med Brux. 2018;39(2):114-115. French. No abstract available.

PMID:
29722494
6.

A phase III randomised study comparing concomitant radiochemotherapy with cisplatin and docetaxel as induction versus consolidation treatment in patients with locally advanced unresectable non-small cell lung cancer.

Sculier JP, Lafitte JJ, Berghmans T, Meert AP, Scherpereel A, Roelandts M, Van Cutsem O, Colinet B, Bonduelle Y, Giner V, Paesmans M, Leclercq N, Van Houtte P.

Lung Cancer. 2018 Mar;117:32-37. doi: 10.1016/j.lungcan.2017.12.016. Epub 2018 Jan 31.

PMID:
29496253
7.

[Impact of routine brain imaging in the initial management of lung cancer].

Niviere P, Sculier JP, Meert AP, Berghmans T.

Rev Mal Respir. 2018 Jan;35(1):55-61. doi: 10.1016/j.rmr.2017.11.004. Epub 2018 Feb 4. French.

PMID:
29397303
8.

[Immune checkpoint inhibitors (antibodies to PD1 and PD-L1), a new therapeutic weapon against non-small cell bronchial carcinoma].

Berghmans T, Grigoriu B, Sculier JP, Meert AP.

Rev Mal Respir. 2018 Feb;35(2):197-205. doi: 10.1016/j.rmr.2017.11.007. Epub 2018 Feb 1. Review. French.

PMID:
29395567
9.

18e Journée annuelle d’Oncologie thoracique (JAOT).

Sculier JP.

Rev Med Brux. 2017;38(5):442-446. French. No abstract available.

PMID:
29178694
10.

Le Laboratoire de Médecine Factuelle (LabMeF) de la Faculté de Médecine de l’ULB.

Sculier JP.

Rev Med Brux. 2017;38(5):405-406. French. No abstract available.

PMID:
29178688
11.

A Phase III Randomized Study Comparing a Chemotherapy with Cisplatin and Etoposide to a Etoposide Regimen without Cisplatin for Patients with Extensive Small-Cell Lung Cancer.

Berghmans T, Scherpereel A, Meert AP, Giner V, Lecomte J, Lafitte JJ, Leclercq N, Paesmans M, Sculier JP; European Lung Cancer Working Party (ELCWP).

Front Oncol. 2017 Sep 19;7:217. doi: 10.3389/fonc.2017.00217. eCollection 2017.

12.

Pain control in thoracic oncology.

Peeters-Asdourian C, Massard G, Rana PH, Van Houtte P, White AP, Grigoriu B, Lossignol D, Almalki M, Alexiou J, Engelholm JL, Sculier JP.

Eur Respir J. 2017 Sep 10;50(3). pii: 1700611. doi: 10.1183/13993003.00611-2017. Print 2017 Sep. Review.

PMID:
28890435
13.

Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature: Part 5: Neurological auto-antibodies, discussion, flow chart, conclusions.

Sculier C, Bentea G, Ruelle L, Grigoriu B, Coureau M, Gorham J, Sideris S, Holbrechts S, Lafitte JJ, Meert AP, Durieux V, Berghmans T, Sculier JP.

Lung Cancer. 2017 Sep;111:164-175. doi: 10.1016/j.lungcan.2017.07.026. Epub 2017 Jul 24. Review.

PMID:
28838389
14.

Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature Part 4: Neurological paraneoplastic syndromes, involving the peripheral nervous system and the neuromuscular junction and muscles.

Ruelle L, Bentea G, Sideris S, El Koulali M, Holbrechts S, Lafitte JJ, Grigoriu B, Sculier C, Meert AP, Durieux V, Berghmans T, Sculier JP.

Lung Cancer. 2017 Sep;111:150-163. doi: 10.1016/j.lungcan.2017.07.025. Epub 2017 Jul 25. Review.

PMID:
28838388
15.

Les Actualités en Médecine factuelle - Edition 2017.

Sculier JP.

Rev Med Brux. 2017;38(3):178-180. French. No abstract available.

PMID:
28653523
16.

La 17e Rencontre Eveline Markiewicz sur les urgences et complications sévères chez le patient cancéreux.

Sculier JP.

Rev Med Brux. 2017;38(2):112-114. French. No abstract available.

PMID:
28525253
17.

Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature: Part 2: Hematologic, cutaneous and vascular syndromes.

Holbrechts S, Gorham J, Sideris S, Meert AP, Durieux V, Berghmans T, Sculier JP.

Lung Cancer. 2017 Apr;106:93-101. doi: 10.1016/j.lungcan.2017.01.016. Epub 2017 Jan 30. Review.

PMID:
28285701
18.

Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature: Part 3: Neurological paraneoplastic syndromes, involving the central nervous system.

Bentea G, Sculier C, Grigoriu B, Meert AP, Durieux V, Berghmans T, Sculier JP.

Lung Cancer. 2017 Apr;106:83-92. doi: 10.1016/j.lungcan.2017.01.017. Epub 2017 Jan 30. Review.

PMID:
28285700
19.

Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature.

Durieux V, Coureau M, Meert AP, Berghmans T, Sculier JP.

Lung Cancer. 2017 Apr;106:102-109. doi: 10.1016/j.lungcan.2017.01.015. Epub 2017 Jan 30. Review.

PMID:
28285683
20.

Thoracic oncology HERMES: European curriculum recommendations for training in thoracic oncology.

Gamarra F, Noël JL, Brunelli A, Dingemans AC, Felip E, Gaga M, Grigoriu BD, Hardavella G, Huber RM, Janes S, Massard G, Putora PM, Sculier JP, Schnabel PA, Ramella S, Van Raemdonck D, Meert AP.

Breathe (Sheff). 2016 Sep;12(3):249-255. doi: 10.1183/20734735.009116. Review.

21.

Are Intensive Cares Worthwhile for Breast Cancer Patients: The Experience of an Oncological ICU.

Destrebecq V, Lieveke A, Berghmans T, Paesmans M, Sculier JP, Meert AP.

Front Med (Lausanne). 2016 Oct 31;3:50. eCollection 2016.

22.

VAC chemotherapy with valproic acid for refractory/relapsing small cell lung cancer: a phase II study.

Berghmans T, Lafitte JJ, Scherpereel A, Ameye L, Paesmans M, Meert AP, Colinet B, Tulippe C, Willems L, Leclercq N, Sculier JP; European Lung Cancer Working Party.

ERJ Open Res. 2015 Oct 19;1(2). pii: 00029-2015. eCollection 2015 Oct.

23.

Multidisciplinary questions in thoracic oncology: the team experience.

Sculier JP.

Eur Respir J. 2016 Sep;48(3):626-7. doi: 10.1183/13993003.00936-2016. No abstract available.

24.

Continuous Renal Replacement Therapy for Acute Renal Failure in Patients with Cancer: A Well-Tolerated Adjunct Treatment.

Fischler R, Meert AP, Sculier JP, Berghmans T.

Front Med (Lausanne). 2016 Aug 3;3:33. doi: 10.3389/fmed.2016.00033. eCollection 2016.

25.

16e Rencontre Eveline Markiewicz sur les urgences et complications sévères chez le patient cancéreux.

Sculier JP.

Rev Med Brux. 2016 Mar-Apr;37(2):123-5. French. No abstract available.

PMID:
27487700
26.

La 16e Journée Annuelle d'Oncologie Thoracique (JAOT).

Sculier JP.

Rev Med Brux. 2016 Jan-Feb;37(1):58-60. French. No abstract available.

PMID:
27120939
27.

[The Glasgow inflammatory score and lung cancer: A predictor of admissions to emergency units].

Gorham J, Ameye L, Paesmans M, Berghmans T, Sculier JP, Meert AP.

Rev Mal Respir. 2016 Nov;33(9):759-765. doi: 10.1016/j.rmr.2016.02.004. Epub 2016 Mar 24. French.

PMID:
27017064
28.

[Difficulties and limitations in conducting translational research in thoracic oncology. A practical example].

Meert AP, Ameye L, Leclercq N, Paesmans M, Remmelink M, Sculier JP, Berghmans T.

Rev Mal Respir. 2016 Sep;33(7):594-9. doi: 10.1016/j.rmr.2015.10.744. Epub 2016 Jan 6. French.

PMID:
26777111
29.

[Oncological intensive care: 2013 and 2014 years'review].

Sculier JP, Bucalau AM, Closset C, Compagnie M, Gorham J, Sideris S, De Roodebeek DT, Wang XX, Berghmans T, Meert AP.

Rev Med Brux. 2016;37(3):159-167. Review. French.

PMID:
28525189
30.

La 17e Journée Annuelle d'Oncologie Thoracique (JAOT).

Sculier JP.

Rev Med Brux. 2016;37(6):501-503. French. No abstract available.

PMID:
28525181
31.

Circulating free DNA, new dynamic marker in nonsmall cell lung cancer patients?

Remon J, Gorham J, Besse B, Sculier JP.

Eur Respir J. 2015 Dec;46(6):1548-50. doi: 10.1183/13993003.01482-2015. No abstract available.

32.

[Implementation of an oncological care program in a multidisciplinary clinic].

Sculier JP, Leclercq N, Meert AP, Paesmans M, Berghmans T.

Rev Mal Respir. 2016 Sep;33(7):600-6. doi: 10.1016/j.rmr.2015.10.741. Epub 2015 Nov 21. French.

PMID:
26611198
33.

Lung cancer screening white paper: a slippery step forward?

Kauczor HU, Bonomo L, Gaga M, Nackaerts K, Peled N, Prokop M, Remy-Jardin M, von Stackelberg O, Sculier JP; European Society of Radiology (ESR) and the European Respiratory Society (ERS).

Eur Respir J. 2015 Nov;46(5):1521-2. doi: 10.1183/13993003.01103-2015. No abstract available.

34.

A message from the ERS President and the ERS Secretary for EU Affairs.

Bel E, Sculier JP.

Eur Respir J. 2015 Nov;46(5):1269. doi: 10.1183/13993003.01427-2015. No abstract available.

35.

Primary tumour standardised uptake value is prognostic in nonsmall cell lung cancer: a multivariate pooled analysis of individual data.

Paesmans M, Garcia C, Wong CY, Patz EF Jr, Komaki R, Eschmann S, Govindan R, Vansteenkiste J, Meert AP, de Jong WK, Altorki NK, Higashi K, Van Baardwijk A, Borst GR, Ameye L, Lafitte JJ, Berghmans T, Flamen P, Rami-Porta R, Sculier JP.

Eur Respir J. 2015 Dec;46(6):1751-61. doi: 10.1183/13993003.00099-2015. Epub 2015 Sep 24.

36.

Health impacts of anthropogenic biomass burning in the developed world.

Sigsgaard T, Forsberg B, Annesi-Maesano I, Blomberg A, Bølling A, Boman C, Bønløkke J, Brauer M, Bruce N, Héroux ME, Hirvonen MR, Kelly F, Künzli N, Lundbäck B, Moshammer H, Noonan C, Pagels J, Sallsten G, Sculier JP, Brunekreef B.

Eur Respir J. 2015 Dec;46(6):1577-88. doi: 10.1183/13993003.01865-2014. Epub 2015 Sep 24.

37.

[The 15th Eveline Markiewicz Meeting on emergencies and severe complications in cancer patients].

Sculier JP.

Rev Med Brux. 2015 Mar-Apr;36(2):117-9. French. No abstract available.

PMID:
26164971
38.

Smoking Control Is a Priority to Promote Heart, Lung, Blood, and Sleep Health.

Jimenez-Ruiz CA, Sculier JP, Lundback B, Vardavas C, Ignacio De Granda Orive J, Katsaounou P, Haslam P, Heederik DJ, Ravara S, Smyth D, Martin F, Gratziou C; ERS Tobacco Control Committee.

Am J Respir Crit Care Med. 2015 Jun 15;191(12):1471-3. doi: 10.1164/rccm.201504-0746LE. No abstract available.

PMID:
26075431
39.

[Renal cysts - A novel complication of crizotinib treatment for lung cancer].

CsToth I, Meert AP, Sculier JP, Berghmans T.

Rev Mal Respir. 2015 Nov;32(9):956-8. doi: 10.1016/j.rmr.2015.01.007. Epub 2015 May 29. French.

PMID:
26033699
40.

ESR/ERS white paper on lung cancer screening.

Kauczor HU, Bonomo L, Gaga M, Nackaerts K, Peled N, Prokop M, Remy-Jardin M, von Stackelberg O, Sculier JP; European Society of Radiology (ESR); European Respiratory Society (ERS).

Eur Respir J. 2015 Jul;46(1):28-39. doi: 10.1183/09031936.00033015. Epub 2015 Apr 30.

41.

ESR/ERS white paper on lung cancer screening.

Kauczor HU, Bonomo L, Gaga M, Nackaerts K, Peled N, Prokop M, Remy-Jardin M, von Stackelberg O, Sculier JP; European Society of Radiology (ESR); European Respiratory Society (ERS).

Eur Radiol. 2015 Sep;25(9):2519-31. doi: 10.1007/s00330-015-3697-0. Epub 2015 May 1.

42.

Lung cancer diagnosis in the emergency department.

Meert AP, Sculier JP, Berghmans T.

Eur Respir J. 2015 Apr;45(4):867-8. doi: 10.1183/09031936.00198814. No abstract available.

43.

Towards tuberculosis elimination: an action framework for low-incidence countries.

Lönnroth K, Migliori GB, Abubakar I, D'Ambrosio L, de Vries G, Diel R, Douglas P, Falzon D, Gaudreau MA, Goletti D, González Ochoa ER, LoBue P, Matteelli A, Njoo H, Solovic I, Story A, Tayeb T, van der Werf MJ, Weil D, Zellweger JP, Abdel Aziz M, Al Lawati MR, Aliberti S, Arrazola de Oñate W, Barreira D, Bhatia V, Blasi F, Bloom A, Bruchfeld J, Castelli F, Centis R, Chemtob D, Cirillo DM, Colorado A, Dadu A, Dahle UR, De Paoli L, Dias HM, Duarte R, Fattorini L, Gaga M, Getahun H, Glaziou P, Goguadze L, Del Granado M, Haas W, Järvinen A, Kwon GY, Mosca D, Nahid P, Nishikiori N, Noguer I, O'Donnell J, Pace-Asciak A, Pompa MG, Popescu GG, Robalo Cordeiro C, Rønning K, Ruhwald M, Sculier JP, Simunović A, Smith-Palmer A, Sotgiu G, Sulis G, Torres-Duque CA, Umeki K, Uplekar M, van Weezenbeek C, Vasankari T, Vitillo RJ, Voniatis C, Wanlin M, Raviglione MC.

Eur Respir J. 2015 Apr;45(4):928-52. doi: 10.1183/09031936.00214014. Review.

44.

Advances in target therapy in lung cancer.

Sculier JP, Berghmans T, Meert AP.

Eur Respir Rev. 2015 Mar;24(135):23-9. doi: 10.1183/09059180.00011014. Review.

45.

Prospective Validation Obtained in a Similar Group of Patients and with Similar High Throughput Biological Tests Failed to Confirm Signatures for Prediction of Response to Chemotherapy and Survival in Advanced NSCLC: A Prospective Study from the European Lung Cancer Working Party.

Berghmans T, Ameye L, Lafitte JJ, Colinet B, Cortot A, CsToth I, Holbrechts S, Lecomte J, Mascaux C, Meert AP, Paesmans M, Richez M, Scherpereel A, Tulippe C, Willems L, Dernies T, Leclercq N, Sculier JP; European Lung Cancer Working Party.

Front Oncol. 2015 Jan 28;4:386. doi: 10.3389/fonc.2014.00386. eCollection 2014.

46.

Admitting lung cancer patients to intensive care for organ dysfunction: a complex decision process.

Meert AP, Berghmans T, Sculier JP.

Eur Respir J. 2015 Feb;45(2):308-9. doi: 10.1183/09031936.00198714. No abstract available.

47.

[15th annual workshop of thoracic oncology (JAOT)].

Sculier JP.

Rev Med Brux. 2014 Nov-Dec;35(6):511-2. French. No abstract available.

PMID:
25619052
48.

Medical anticancer treatment of lung cancer associated with comorbidities: a review.

Sculier JP, Botta I, Bucalau AM, Compagnie M, Eskenazi A, Fischler R, Gorham J, Mans L, Rozen L, Speybrouck S, Wang X, Meert AP, Berghmans T.

Lung Cancer. 2015 Mar;87(3):241-8. doi: 10.1016/j.lungcan.2015.01.007. Epub 2015 Jan 16. Review.

PMID:
25617984
49.

Systematic qualitative review of randomised trials conducted in nonsmall cell lung cancer with a noninferiority or equivalence design.

Paesmans M, Grigoriu B, Ocak S, Roelandts M, Lafitte JJ, Holbrechts S, Berghmans T, Meert AP, Moretti L, Danyi S, Pasleau F, Ameye L, Van Meerhaeghe A, Sculier JP.

Eur Respir J. 2015 Feb;45(2):511-24. doi: 10.1183/09031936.00092814. Epub 2014 Dec 23. Review.

50.

[The patient with lung cancer in intensive care].

Meert AP, Berghmans T, Sculier JP.

Rev Mal Respir. 2014 Dec;31(10):961-74. doi: 10.1016/j.rmr.2014.08.001. Epub 2014 Oct 31. Review. French.

PMID:
25496791

Supplemental Content

Loading ...
Support Center